Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. nightwatch

NIGHTWATCH SIGNED

NightWatch - Clinically-proven detection and alert system for critical nocturnal epileptic seizures.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NIGHTWATCH project word cloud

Explore the words cloud of the NIGHTWATCH project. It provides you a very rough idea of what is the project "NIGHTWATCH" about.

28    adapting    lack    wirelessly    specialised    prevented    independency    giving    epilepsy    patient    device    more    flagship    north    reduces    uses    peace    few    remote    40    uncontrolled    algorithm    gt    nightwatch    spin    anxiety    company    patients    conceived    attending    false    leads    2019    bracelet    19m    seek    reducing    monitor    rate    least    seizures    types    accumulated    90    dutch    heart    seconds    livassured    50m    heavy    patterns    quality    30    time    wearables    people    improves    market    sudden    intramural    life    social    societal    professionals    continuous    care    followed    caregivers    preferred    commercial    self    critical    depression    notifies    die    institutes    unexpected    suffer    monitoring    combination    clinically    prevents    medication    sudep    wards    alarm    detect    nocturnal    relief    trend    caused    severe    pushing    automatically    minimize    profit    home    33    2013    46    ai    mind    billion    america    urgent    worldwide    sleep    medical    full    tele    tested    4    off    death    roi    detects    deaths    movement    registered    despite    created    seizure   

Project "NIGHTWATCH" data sheet

The following table provides information about the project.

Coordinator		 LIVASSURED BV 

Organization address
address: ALBERTUSSTRAAT 34
city: VUGHT
postcode: 5261AD
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Netherlands [NL]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-12-01   to  2020-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LIVASSURED BV NL (VUGHT) coordinator 50˙000.00

Map

 Project objective

More than 50M people worldwide suffer from epilepsy, characterized by uncontrolled seizures, and about 30% find no relief from those despite taking medication. Nocturnal seizures can be critical; each year at least 33.000 people in EU die of Sudden Unexpected Death in Epilepsy (SUDEP), 40% of which could be prevented by attending the seizures on time. This is a continuous challenge for patients and caregivers, with important social and societal consequences (anxiety, depression, lack of sleep), and high intramural care costs (over €20 billion per year in EU). The NightWatch is a registered medical device that detects and notifies wirelessly remote caregivers in case of heavy nocturnal seizures in just few seconds. The bracelet uses a combination of heart rate and movement measurement, a unique AI algorithm conceived by three Dutch institutes specialised in epilepsy, automatically adapting to different patient patterns to minimize false alarm rate. It has been clinically tested and can detect > 90% of all types of urgent nocturnal seizures making it the most reliable system available. The NightWatch targets caregivers, patients and professionals who seek an effective alarm system for severe nocturnal seizures. It improves their quality of life giving them peace of mind, higher level of independency, reduces cost of care by reducing the need for intramural attention, and prevents deaths caused by SUDEP. With a trend to-wards home care and self-monitoring pushing market growth (expected to reach €4.0 billion in 2019), wearables becoming the preferred type of seizure monitoring. EU leads the seizure monitor devices market (46%), followed by North America (28%). NightWatch is the flagship product of LivAssured, a Dutch company created in 2013 as a spin-off to take over the commercial exploitation of the research results of the Tele-Epilepsy Consortium on nocturnal seizures. With its full commercial exploitation, we expect an accumulated profit of €19M and a ROI of 4

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NIGHTWATCH" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NIGHTWATCH" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

VINOQUANT11SUPERPLUS (2019)

A digital based system for measuring, showing and regulation of the complexe system of wine feremtation with high precision via a Bluetooth -Refractometer, a Software and a Bluetooth Thermostat

Read More